Literature DB >> 3137164

Growth of Mycobacterium avium in activated macrophages harvested from inbred mice with differing innate susceptibilities to mycobacterial infection.

R W Stokes1, F M Collins.   

Abstract

The growth of Mycobacterium avium in macrophages obtained from Mycobacterium bovis BCG-infected mice was compared with that in macrophages from uninfected mice. BCG vaccination resulted in substantial macrophage activation, measured as increased acid phosphatase and superoxide anion production, as well as enhanced leishmanicidal activity. However, the activated macrophages were only able to reduce the rate of intracellular growth by Listeria monocytogenes and M. avium in vivo and did not express detectable levels of mycobactericidal activity in vitro. Exposure of the macrophage monolayers to concanavalin A-stimulated spleen cell supernatant fluid and lipopolysaccharide did not further enhance the ability of the BCG-activated macrophages to control the intracellular replication of the M. avium. Macrophages from BCG-infected C57BL/6 (BCGs) mice were quantitatively better able to control the intracellular replication of the M. avium challenge than were similar phagocytes obtained from BCGr (A/J) mice. These findings have important implications with respect to the expression of acquired resistance to these atypical mycobacterial infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137164      PMCID: PMC259557          DOI: 10.1128/iai.56.9.2250-2254.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

Review 1.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

2.  Lymphocyte-mediated modification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphokines.

Authors:  T Godal; R J Rees; J O Lamvik
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

3.  A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells.

Authors:  A Nakagawara; C F Nathan
Journal:  J Immunol Methods       Date:  1983-01-28       Impact factor: 2.303

4.  Preliminary demonstration of human tuberculoimmunity in vitro.

Authors:  A J Crowle; M May
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

5.  Inhibition of virulent Mycobacterium tuberculosis by murine peritoneal macrophages and human alveolar lavage cells: the effects of lymphokines and recombinant gamma interferon.

Authors:  J Steele; K C Flint; A L Pozniak; B Hudspith; M M Johnson; G A Rook
Journal:  Tubercle       Date:  1986-12

6.  Immune responses to atypical mycobacterial lung infections.

Authors:  F M Collins; S R Watson
Journal:  Rev Infect Dis       Date:  1981 Sep-Oct

7.  Effects of BCG infection on the susceptibility of mouse macrophages to endotoxin.

Authors:  D L Peavy; R E Baughn; D M Musher; D M Musher
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

8.  Growth of Mycobacterium lepraemurium in nonstimulated and stimulated mouse peritoneal-derived and bone marrrow-derived macrophages in vitro.

Authors:  J Alexander; C C Smith
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

9.  Immune response to persistent mycobacterial infection in mice.

Authors:  F M Collins; N E Morrison; V Montalbine
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

10.  Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.

Authors:  S L James; E Skamene; M S Meltzer
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

View more
  10 in total

1.  Intramacrophage growth of Mycobacterium avium during infection of mice.

Authors:  C Frehel; C de Chastellier; C Offredo; P Berche
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.

Authors:  R Appelberg; A M Sarmento
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Passive transfer of immunity of Mycobacterium avium in susceptible and resistant strains of mice.

Authors:  R W Stokes; F M Collins
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

4.  Induction and expression of protective T cells during Mycobacterium avium infections in mice.

Authors:  R Appelberg; J Pedrosa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

5.  Intramacrophagic Mycobacterium avium bacilli are coated by a multiple lamellar structure: freeze fracture analysis of infected mouse liver.

Authors:  S Rulong; A P Aguas; P P da Silva; M T Silva
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Implication of phagosome-lysosome fusion in restriction of Mycobacterium avium growth in bone marrow macrophages from genetically resistant mice.

Authors:  C de Chastellier; C Fréhel; C Offredo; E Skamene
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

7.  Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: establishment of latency and reactivation.

Authors:  D H Brown; B A Miles; B S Zwilling
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

8.  Immunomodulation of mouse macrophage killing of Mycobacterium avium in vitro.

Authors:  R D Hubbard; F M Collins
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.

Authors:  M Denis
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

10.  Memory T cell-mediated resistance to Mycobacterium tuberculosis infection in innately susceptible and resistant mice.

Authors:  R D Hubbard; C M Flory; F M Collins
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.